Fennec Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $13,988 | $12,462 | $9,652 | $8,751 |
Gross Profit | 12,197 | 11,802 | 8,685 | 8,378 |
EBITDA | -3,062 | -1 | -2,533 | -782 |
EBIT | -52 | -2,558 | -808 | |
Net Income | -5,223 | -638 | -3,152 | -1,165 |
Net Change In Cash | 13,988 | 12,462 | 9,652 | 8,751 |
Free Cash Flow | -5,962 | 1,493 | -3,686 | -4,318 |
Cash | 36,721 | 21,925 | 18,705 | 22,675 |
Basic Shares | 31,175 | 27,889 | 27,664 | 27,578 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $45,423 | $47,538 | $21,252 | $1,474 |
Gross Profit | 41,593 | 44,354 | 19,993 | 1,391 |
EBITDA | -6,862 | 4,798 | -12,364 | -21,692 |
EBIT | 3,998 | -12,651 | -22,736 | |
Net Income | -10,274 | -436 | -16,045 | -22,774 |
Net Change In Cash | 45,423 | 47,538 | 21,252 | 1,474 |
Free Cash Flow | -12,473 | 26,980 | -17,143 | -18,058 |
Cash | 36,721 | 26,634 | 13,269 | 23,774 |
Basic Shares | 28,577 | 27,294 | 26,574 | 26,275 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.10 |
2025-09-30 | -$0.02 |
2025-06-30 | -$0.11 |
